Oncotarget

Corrections:

Correction: A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratory

PDF  |  How to cite

Oncotarget. 2019; 10:5254-5254. https://doi.org/10.18632/oncotarget.27176

Metrics: PDF 1285 views  |   ?  

Natalia Paez Arango1, Lauren Brusco2, Kenna R. Mills Shaw2, Ken Chen3, Agda Karina Eterovic4, Vijaykumar Holla2, Amber Johnson2, Beate Litzenburger2, Yekaterina B. Khotskaya2, Nora Sanchez2, Ann Bailey2, Xiaofeng Zheng3, Chacha Horombe2, Scott Kopetz5, Carol J. Farhangfar6, Mark Routbort7, Russell Broaddus8, Elmer V. Bernstam9,10, John Mendelsohn2,11, Gordon B. Mills2,4 and Funda Meric- Bernstam1,2,12

1 Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
2 Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
3 Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
4 Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
5 Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
6 Levine Cancer Institute, Carolinas Healthcare System, Charlotte, NC, USA
7 Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
8 Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
9 School of Biomedical Informatics, The University of Texas Health Science Center at Houston, TX, USA
10 Division of General Internal Medicine, Medical School, The University of Texas Health Science Center at Houston, TX, USA
11 Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
12 Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Published: August 27, 2019

This article has been corrected: The Acknowledgements information has been updated. The proper Acknowledgements section is shown below:

ACKNOWLEDGMENTS

This work was supported in part by NCI 5T32CA009599, CPRIT RP 150535, the Sheikh Khalifa Al Nahyan Ben Zayed Institute for Personalized Cancer Therapy, NCI U01 CA180964, NCATS grant UL1 TR000371 (Center for Clinical and Translational Sciences), the Nellie B. Connally Breast Cancer Research Endowment, and the MD Anderson Cancer Center Support Grant (CCSG) (P30 CA016672) and the CCSG supported Sequencing and Microarray Facility (SMF).

Original article: Oncotarget. 2017; 8:41806–41814. DOI: https://doi.org/10.18632/oncotarget.16018.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 27176